Cargando…
Immunological profile of an infant treated with integrase inhibitor from the neonatal period
Autores principales: | Taramasso, Lucia, Dentone, Chiara, Tatarelli, Paola, Bruzzone, Bianca, Marras, Francesco, De Maria, Andrea, Gotta, Cristina, Castagnola, Elio, Filaci, Gilberto, Viscoli, Claudio, Fenoglio, Daniela, Di Biagio, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362908/ https://www.ncbi.nlm.nih.gov/pubmed/30800427 |
Ejemplares similares
-
Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV
por: Filaci, Gilberto, et al.
Publicado: (2018) -
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL
por: Dentone, Chiara, et al.
Publicado: (2014) -
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity
por: Bozzano, Federica, et al.
Publicado: (2021) -
Prophylaxis and Empirical Therapy of Infection in Cancer Patients
por: Castagnola, Elio, et al.
Publicado: (2015) -
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials
por: Fraccaro, Paolo, et al.
Publicado: (2013)